Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 131 articles: HTML format

Single Articles

October 2023
1. SHEN Y, Yang TH, Deng X, Wu Q, et al
   Closure of pelvic peritoneum with bladder peritoneum flap reconstruction after laparoscopic extralevator abdominoperineal excision: A prospective stage II study.
   J Surg Oncol. 2023;128:851-859.
   PubMed     Abstract available
   
   
   
2. GHABRA S, Chang D, Sugarbaker PH
   Prognostic indicators for colorectal peritoneal metastases are different for patients with complete versus incomplete cytoreductive surgery.
   J Surg Oncol. 2023;128:860-868.
   PubMed     Abstract available
   
   
   September 2023
3. NUMATA K, Numata M, Shirai J, Sawazaki S, et al
   Short- and long-term outcomes of transanal decompression tube and self-expandable metallic stent for obstructive colorectal cancer based on a multicenter database (KYCC2110).
   J Surg Oncol. 2023 Sep 27. doi: 10.1002/jso.27454.
   PubMed     Abstract available
   
   
   
4. ENDO Y, Rueda BO, Woldesenbet S, Munir MM, et al
   The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases.
   J Surg Oncol. 2023;128:560-568.
   PubMed     Abstract available
   
   
   
5. YANG XY, Hu Q
   Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
   J Surg Oncol. 2023;128:701-703.
   PubMed    
   
   
   
6. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
   Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
   J Surg Oncol. 2023;128:585-594.
   PubMed     Abstract available
   
   
   August 2023
7. KOZMAN MA, Fisher OM, Liauw W, Morris DL, et al
   External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy.
   J Surg Oncol. 2023 Aug 21. doi: 10.1002/jso.27416.
   PubMed     Abstract available
   
   
   
8. LIN WL, Wu LM, Huang WT, Guo HR, et al
   Age as a modifier of the effects of sarcopenia on survival among colon cancer patients after surgery.
   J Surg Oncol. 2023 Aug 17. doi: 10.1002/jso.27405.
   PubMed     Abstract available
   
   
   
9. XIAO J, Shen Y, Yang X, Zeng H, et al
   The same parastomal hernia repairs rate in the different approaches to colostomy.
   J Surg Oncol. 2023;128:304-312.
   PubMed     Abstract available
   
   
   July 2023
10. COHEN R, Platell CF
    Metachronous colorectal cancer metastasis: Who, what, when and what to do about it.
    J Surg Oncol. 2023 Jul 17. doi: 10.1002/jso.27400.
    PubMed     Abstract available
    
    
    
11. RADOMSKI SN, Chen SY, Stem M, Done JZ, et al
    Simultaneous resection of colorectal cancer and synchronous colorectal liver metastases: A risk stratified analysis of the NSQIP database.
    J Surg Oncol. 2023 Jul 13. doi: 10.1002/jso.27393.
    PubMed     Abstract available
    
    
    
12. FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al
    Anorectal melanoma.
    J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381.
    PubMed     Abstract available
    
    
    
13. BEDRIKOVETSKI S, Traeger L, Sammour T
    Reply to Letter to the Editor: Can sarcopenia predict complete response after Total Neoadjuvant Therapy in advanced rectal cancer? A multicentre observational cohort study.
    J Surg Oncol. 2023;128:181-182.
    PubMed    
    
    
    
14. YANG XY, Hu Q
    Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer?
    J Surg Oncol. 2023;128:179-180.
    PubMed    
    
    
    
15. BEDRIKOVETSKI S, Traeger L, Price TJ, Carruthers S, et al
    Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study.
    J Surg Oncol. 2023;128:75-84.
    PubMed     Abstract available
    
    
    
16. ROUHI AD, Muhammad HA, Lee B, Eng OS, et al
    Improving online resources for cytoreductive surgery and HIPEC by engaging patients.
    J Surg Oncol. 2023;128:175-176.
    PubMed    
    
    
    
17. EFETOV SK, Zubayraeva AA, Panova PD, Cao Y, et al
    Transrectal specimen extraction (NOSES II) for the laparoscopic distal sigmoid colon resection with mesocolic complete lymph node dissection (video correspondence).
    J Surg Oncol. 2023;128:85-86.
    PubMed    
    
    
    
18. WAGSTAFF JFR, Flood MP, Mohan H, McBain RD, et al
    Perioperative outcomes of cytoreductive surgery for tumours of colorectal or appendiceal origin with ovarian involvement.
    J Surg Oncol. 2023;128:66-74.
    PubMed     Abstract available
    
    
    June 2023
19. LEE JM, Han YD, Cho MS, Hur H, et al
    Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    J Surg Oncol. 2023 Jun 8. doi: 10.1002/jso.27308.
    PubMed     Abstract available
    
    
    
20. MUNIR MM, Woldesenbet S, Alaimo L, Moazzam Z, et al
    Mediators of county-level racial and economic privilege in cancer screening.
    J Surg Oncol. 2023;127:1212-1222.
    PubMed     Abstract available
    
    
    
21. HE Q, Huang J, Niu L, Zhai C, et al
    A comparison of the efficacy and safety of natural orifice specimen extraction and conventional laparoscopic surgery in patients with sigmoid colon/high rectal cancer.
    J Surg Oncol. 2023;127:1160-1166.
    PubMed     Abstract available
    
    
    
22. HERNANDEZ MC, Wong P, Melstrom K
    Low anterior resection syndrome.
    J Surg Oncol. 2023;127:1271-1276.
    PubMed     Abstract available
    
    
    
23. LEIPHRAKPAM PD, Rajappa SJ, Krishnan M, Batra R, et al
    Colorectal cancer: Review of signaling pathways and associated therapeutic strategies.
    J Surg Oncol. 2023;127:1277-1295.
    PubMed     Abstract available
    
    
    
24. KIM BJ, Hanna MH
    Colorectal cancer in young adults.
    J Surg Oncol. 2023;127:1247-1251.
    PubMed     Abstract available
    
    
    
25. WILLIAMS JR, Ayscue JM
    Colorectal cancer screening: A review of current screening options, timing, and guidelines.
    J Surg Oncol. 2023;127:1236-1246.
    PubMed     Abstract available
    
    
    
26. KHALIL M, Abbass MA
    Neoadjuvant immunotherapy in microsatellite unstable colorectal cancer: Are we in the era of nonoperative management?
    J Surg Oncol. 2023;127:1296-1299.
    PubMed     Abstract available
    
    
    
27. RAMIREZ R, Donohue K
    Current monitoring and treatment for anal intraepithelial neoplasms.
    J Surg Oncol. 2023;127:1306-1309.
    PubMed     Abstract available
    
    
    
28. CHANG G, Halabi WJ, Ali F
    Management of lateral pelvic lymph nodes in rectal cancer.
    J Surg Oncol. 2023;127:1264-1270.
    PubMed     Abstract available
    
    
    
29. ABBASS MA, Church J
    Contemporary surgical management of colorectal cancer in Lynch syndrome.
    J Surg Oncol. 2023;127:1259-1263.
    PubMed     Abstract available
    
    
    
30. BOBEL MC, McGee MF
    Determining the optimal radiation-surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma.
    J Surg Oncol. 2023;127:1252-1258.
    PubMed     Abstract available
    
    
    May 2023
31. JADE F, Marc P, Gabriel L, Clarisse E, et al
    A prediction model to refine the timing of an early second-look laparoscopic exploration in patients with colon cancer at high risk of early peritoneal metastasis recurrence.
    J Surg Oncol. 2023 May 25. doi: 10.1002/jso.27359.
    PubMed     Abstract available
    
    
    
32. GOFFREDO P, Aguirre N, Mohamed M, Kleiman DA, et al
    Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group.
    J Surg Oncol. 2023;127:1028-1034.
    PubMed     Abstract available
    
    
    
33. LEHTONEN TM, Ilvesmaki A, Koskenvuo LE, Lepisto AH, et al
    The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer.
    J Surg Oncol. 2023;127:991-998.
    PubMed     Abstract available
    
    
    
34. KATO PJ, Kanters AE, Rivard SJ, Hendren S, et al
    Comparison of surgeon and pathologist total mesorectal excision grade after rectal cancer resection: A single institution analysis.
    J Surg Oncol. 2023;127:983-990.
    PubMed     Abstract available
    
    
    April 2023
35. MOGOLLON-GONZALEZ M, Conde-Muino R, Rodriguez-Fernandez A, Navarro-Pelayo M, et al
    Impact of routine preoperative (18) FDG PET/CT on the surgical management of primary colorectal cancer.
    J Surg Oncol. 2023 Apr 24. doi: 10.1002/jso.27291.
    PubMed     Abstract available
    
    
    
36. MORGAN RB, Dhiman A, Sood D, Ong CT, et al
    Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
    J Surg Oncol. 2023;127:831-840.
    PubMed     Abstract available
    
    
    
37. FLEMING AM, Deschner BW, Williard FW, Drake JA, et al
    Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
    J Surg Oncol. 2023;127:815-822.
    PubMed     Abstract available
    
    
    
38. VAN KOOTEN RT, Ravensbergen CJ, van Buseck SCD, Grootjans W, et al
    Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
    J Surg Oncol. 2023;127:823-830.
    PubMed     Abstract available
    
    
    
39. HANSDOTTER P, Scherman P, Nikberg M, Petersen SH, et al
    Treatment and survival of patients with metachronous colorectal lung metastases.
    J Surg Oncol. 2023;127:806-814.
    PubMed     Abstract available
    
    
    
40. KERAMATI MR, Meshkati Yazd SM, Shahriarirad R, Ahmadi Tafti SM, et al
    Hand-sewn direct repair versus resection and hand-sewn anastomosis techniques for the reversal of diverting loop ileostomy after lower anterior rectal resection surgery: A randomized clinical trial.
    J Surg Oncol. 2023;127:798-805.
    PubMed     Abstract available
    
    
    March 2023
41. MANKARIOUS MM, Portolese AC, Hoskins MA, Deutsch MJ, et al
    Neoadjuvant chemotherapy does not increase risk for anastomotic leak for simultaneous resection of primary colon cancer with synchronous liver metastasis: A NSQIP-colectomy analysis.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27242.
    PubMed     Abstract available
    
    
    
42. CUK P, Simonsen RM, Sherzai S, Buchbjerg T, et al
    Surgical efficacy and learning curves of laparoscopic complete mesocolic excision with intracorporeal anastomosis for right-sided colon cancer: A retrospective two-center cohort study.
    J Surg Oncol. 2023 Mar 18. doi: 10.1002/jso.27230.
    PubMed     Abstract available
    
    
    
43. SHAIKH CF, Woldesenbet S, Munir MM, Moazzam Z, et al
    Association between the environmental quality index and textbook outcomes among Medicare beneficiaries undergoing surgery for colorectal cancer (CRC).
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27229.
    PubMed     Abstract available
    
    
    
44. TREASURE T, Macbeth F
    Finding that outcomes after imaging-guided thermal ablation and surgery for colorectal lung metastases are similar does not prove a survival benefit from either.
    J Surg Oncol. 2023;127:510-512.
    PubMed    
    
    
    
45. HANNA DN, Macfie R, Ghani MO, Hermina A, et al
    A total neoadjuvant chemotherapy approach is associated with improved recurrence-free survival in patients with colorectal peritoneal metastases undergoing cytoreductive surgery and HIPEC.
    J Surg Oncol. 2023;127:442-449.
    PubMed     Abstract available
    
    
    
46. EDWARDS MURPHY A, Earley H, Creavin B, McCullough P, et al
    A palliative stent for an acute large bowel obstruction-A video vignette.
    J Surg Oncol. 2023;127:441.
    PubMed    
    
    
    
47. SEUX H, Gignoux B, Blanchet MC, Frering V, et al
    Ambulatory colectomy for cancer: Results from a prospective bicentric study of 177 patients.
    J Surg Oncol. 2023;127:434-440.
    PubMed     Abstract available
    
    
    
48. MANGIERI CW, Valenzuela CD, Solsky IB, Erali RA, et al
    Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
    J Surg Oncol. 2023;127:450-456.
    PubMed     Abstract available
    
    
    
49. NEARY C, O'Brien L, McCormack E, Kelly M, et al
    Defining a textbook outcome for the resection of colorectal liver metastases.
    J Surg Oncol. 2023;127:616-624.
    PubMed     Abstract available
    
    
    
50. PARK SY, Park JS, Kim HJ, Kim JG, et al
    Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi-institutional retrospective analysis.
    J Surg Oncol. 2023;127:668-677.
    PubMed     Abstract available
    
    
    February 2023
51. ALAIMO L, Moazzam Z, Woldesenbet S, Lima HA, et al
    Artificial intelligence to investigate predictors and prognostic impact of time to surgery in colon cancer.
    J Surg Oncol. 2023 Feb 25. doi: 10.1002/jso.27224.
    PubMed     Abstract available
    
    
    
52. KHAN H, Radomski SN, Siddiqi A, Zhou N, et al
    Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    J Surg Oncol. 2023 Feb 15. doi: 10.1002/jso.27207.
    PubMed     Abstract available
    
    
    January 2023
53. KHAMZINA S, Lee J, Ryoo SB, Kim MJ, et al
    Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20-year single-center experience & propensity-score matching.
    J Surg Oncol. 2023;127:119-131.
    PubMed     Abstract available
    
    
    December 2022
54. AIKEN T, Hu CY, Uppal A, Francescatti AB, et al
    Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis.
    J Surg Oncol. 2022 Dec 15. doi: 10.1002/jso.27175.
    PubMed     Abstract available
    
    
    
55. VALENZUELA CD, Moaven O, Gawdi R, Stauffer JA, et al
    Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC).
    J Surg Oncol. 2022;126:1242-1252.
    PubMed     Abstract available
    
    
    
56. KIMURA J, Sui K, Murokawa T, Tabuchi M, et al
    Reconsideration of indications for third hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2022;126:1232-1241.
    PubMed     Abstract available
    
    
    
57. NAFFOUJE SA, Manguso N, Imanirad I, Sahin IH, et al
    Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
    J Surg Oncol. 2022;126:1219-1231.
    PubMed     Abstract available
    
    
    
58. LEE KC, Zhao B, Pianka K, Liu S, et al
    Current trends in nonoperative management for rectal adenocarcinoma: An unequal playing field?
    J Surg Oncol. 2022;126:1504-1511.
    PubMed     Abstract available
    
    
    
59. FENG Q, Tang W, Zhang Z, Wei Y, et al
    Robotic versus laparoscopic abdominoperineal resections for low rectal cancer: A single-center randomized controlled trial.
    J Surg Oncol. 2022;126:1481-1493.
    PubMed     Abstract available
    
    
    November 2022
60. MALHOTRA G, Lafaro K, Konstantinidis I, Melstrom L, et al
    Tumor extent impacts survival benefit in minimally invasive colectomy for T4 colon cancer: A propensity matched national cohort analysis.
    J Surg Oncol. 2022 Nov 28. doi: 10.1002/jso.27162.
    PubMed     Abstract available
    
    
    
61. KARAM E, Tabutin M, Dupre A
    Neither surveillance nor treatment showed significant survival benefit for lung metastases from colorectal cancer, imaging guided thermal ablation is a safe and efficient alternative to surgery.
    J Surg Oncol. 2022 Nov 17. doi: 10.1002/jso.27148.
    PubMed    
    
    
    
62. AYLWARD C, Noori J, Tyrrell J, O'sullivan N, et al
    Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: A systematic review.
    J Surg Oncol. 2022 Nov 9. doi: 10.1002/jso.27139.
    PubMed     Abstract available
    
    
    October 2022
63. RUBINSTEIN JC, Foroughi Pour A, Zhou J, Sheridan TB, et al
    Deep learning image analysis quantifies tumor heterogeneity and identifies microsatellite instability in colon cancer.
    J Surg Oncol. 2022 Oct 17. doi: 10.1002/jso.27118.
    PubMed     Abstract available
    
    
    
64. PATY PB, Garcia-Aguilar J
    Colorectal cancer.
    J Surg Oncol. 2022;126:881-887.
    PubMed     Abstract available
    
    
    September 2022
65. KARAM E, Tabutin M, Mastier C, Crignis L, et al
    Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
    J Surg Oncol. 2022 Sep 28. doi: 10.1002/jso.27108.
    PubMed     Abstract available
    
    
    
66. ULANJA MB, Ntafam C, Beutler BD, Antwi-Amoabeng D, et al
    Race, age, and sex differences on the influence of obesity on colorectal cancer sidedness and mortality: A national cross-sectional study.
    J Surg Oncol. 2022 Sep 16. doi: 10.1002/jso.27096.
    PubMed     Abstract available
    
    
    
67. WAGMAN LD, Geller DA, Jacobs SA, Petrelli NJ, et al
    NSABP FC-6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild-type liver metastases receiving mFOLFOX7 plus cetuximab.
    J Surg Oncol. 2022 Sep 16. doi: 10.1002/jso.27078.
    PubMed     Abstract available
    
    
    
68. WALKER BS, Billingsley KG, Sutton TL, Kolbeck KJ, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
    J Surg Oncol. 2022;126:513-522.
    PubMed     Abstract available
    
    
    
69. EMILE SH, Madbouly KM, Elfeki H, Shalaby M, et al
    Multicenter validation of the PREDICT score for prediction of local recurrence after total mesorectal excision of rectal cancer.
    J Surg Oncol. 2022;126:772-780.
    PubMed     Abstract available
    
    
    
70. SOBRADO LF, Nahas CSR, Marques CFS, Sobrado CW, et al
    Pretreatment colostomy in patients with anal squamous cell carcinoma: Risk factors for a permanent stoma.
    J Surg Oncol. 2022;126:740-747.
    PubMed     Abstract available
    
    
    
71. HAYES IP, Milanzi E, Pelly RM, Gibbs P, et al
    T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.
    J Surg Oncol. 2022;126:728-739.
    PubMed     Abstract available
    
    
    August 2022
72. SHARON CE, Song Y, Straker RJ 3rd, Kelly N, et al
    Impact of the affordable care act's medicaid expansion on presentation stage and perioperative outcomes of colorectal cancer.
    J Surg Oncol. 2022 Aug 19. doi: 10.1002/jso.27070.
    PubMed     Abstract available
    
    
    
73. GAWDI R, Valenzuela CD, Moaven O, Stauffer JA, et al
    Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    J Surg Oncol. 2022;126:339-347.
    PubMed     Abstract available
    
    
    
74. GUGUSHEFF J, White K, Fitzadam S, Creighton N, et al
    Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer.
    J Surg Oncol. 2022;126:322-329.
    PubMed     Abstract available
    
    
    July 2022
75. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Reply to Comment on "Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
    J Surg Oncol. 2022 Jul 29. doi: 10.1002/jso.27037.
    PubMed    
    
    
    
76. ZOU M, Xu M, Wu WQ, Gao F, et al
    Comment on "Risk factors for metachronous peritonealcarcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
    J Surg Oncol. 2022 Jul 29. doi: 10.1002/jso.27001.
    PubMed    
    
    
    
77. DUMONT F, Loaec C, Wernert R, Maurel B, et al
    Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control.
    J Surg Oncol. 2022 Jul 2. doi: 10.1002/jso.26990.
    PubMed     Abstract available
    
    
    
78. VAZ DA SILVA DG, Bredt LC, Diniz AL, Vieira VHR, et al
    Brazilian Society of Surgical Oncology surgical standards for resectable colorectal cancer liver metastases.
    J Surg Oncol. 2022;126:28-36.
    PubMed     Abstract available
    
    
    
79. GUMIERO JL, Oliveira BMS, Neto PAO, Pandini RV, et al
    Timing of resection of synchronous colorectal liver metastasis: A systematic review and meta-analysis.
    J Surg Oncol. 2022;126:175-188.
    PubMed     Abstract available
    
    
    June 2022
80. GRANT RRC, Khan TM, Gregory SN, Coakley BA, et al
    Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis.
    J Surg Oncol. 2022 Jun 14. doi: 10.1002/jso.26970.
    PubMed     Abstract available
    
    
    
81. JIN L, Hu Q, Sun Y
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Jun 7. doi: 10.1002/jso.26886.
    PubMed    
    
    
    
82. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer.
    J Surg Oncol. 2022 Jun 4. doi: 10.1002/jso.26975.
    PubMed     Abstract available
    
    
    
83. HU Q, Zhu KF, Sun J
    Preoperative c-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
    J Surg Oncol. 2022 Jun 2. doi: 10.1002/jso.26927.
    PubMed    
    
    
    
84. WU J, Huang Z
    Reply to the comments on "Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer".
    J Surg Oncol. 2022 Jun 2. doi: 10.1002/jso.26968.
    PubMed    
    
    
    
85. SUGARBAKER PH, Ghabra S
    Protocols versus practice in the management of colorectal peritoneal metastases.
    J Surg Oncol. 2022;125:1200-1201.
    PubMed    
    
    
    
86. SUTTON TL, Wong LH, Walker BS, Dewey EN, et al
    Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
    J Surg Oncol. 2022;125:1260-1268.
    PubMed     Abstract available
    
    
    May 2022
87. CUIJPERS ACM, Lubbers T, van Rens HA, Smit-Fun V, et al
    The patient perspective on the preoperative colorectal cancer care pathway and preparedness for surgery and postoperative recovery-a qualitative interview study.
    J Surg Oncol. 2022 May 17. doi: 10.1002/jso.26920.
    PubMed     Abstract available
    
    
    
88. YAN XL, Wang K, Bao Q, Wang HW, et al
    Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
    J Surg Oncol. 2022;125:1002-1012.
    PubMed     Abstract available
    
    
    
89. MASSUCCO P, Fontana AP, Balbo Mussetto A, Desana B, et al
    MRI-detected extramural vascular invasion (mrEMVI) as the best predictive factor to identify candidates to total neoadjuvant therapy in locally advanced rectal cancer.
    J Surg Oncol. 2022;125:1024-1031.
    PubMed     Abstract available
    
    
    
90. HAN J, Wang X, Zhang C, Wu Q, et al
    Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases.
    J Surg Oncol. 2022;125:991-1001.
    PubMed     Abstract available
    
    
    April 2022
91. HAYES IP, Milanzi E, Gibbs P, Faragher I, et al
    Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?
    J Surg Oncol. 2022 Apr 28. doi: 10.1002/jso.26913.
    PubMed     Abstract available
    
    
    
92. JULIO C, Benoist S, Allard MA, Navarro F, et al
    Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer.
    J Surg Oncol. 2022 Apr 9. doi: 10.1002/jso.26885.
    PubMed     Abstract available
    
    
    
93. SUGARBAKER PH, Chang D
    Revised prognostic indicators for treatment of lymph node positive colorectal peritoneal metastases.
    J Surg Oncol. 2022;125:889-900.
    PubMed     Abstract available
    
    
    
94. MADBOULY KM, Emile SH, Gamal AA
    Transanal total mesorectal excision (TaTME) with delayed coloanal anastomosis versus TaTME with immediate coloanal anastomosis and temporary diversion in middle and low rectal cancer.
    J Surg Oncol. 2022;125:865-871.
    PubMed     Abstract available
    
    
    March 2022
95. CHEN P, Hu Q, Sun Y
    Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26849.
    PubMed    
    
    
    
96. HU Q, Sun Y, Yang X
    Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26837.
    PubMed    
    
    
    
97. HU Q, Sun YS, Yang XY
    What are the factors predictive of postoperative complications in patients with colorectal cancer undergoing stenting as a bridge to surgery?
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26824.
    PubMed    
    
    
    
98. CUIJPERS ACM, Bongers BC, Stassen PS, Lubbers T, et al
    Reply letter to the editor: Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Mar 29. doi: 10.1002/jso.26878.
    PubMed    
    
    
    
99. ZORRILLA-VACA A, Ripolles-Melchor J, Abad-Motos A, Mingu IR, et al
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Mar 2. doi: 10.1002/jso.26836.
    PubMed     Abstract available
    
    
    
100. MEI F, Yang X, Na L, Yang L, et al
     Anal preservation on the psychology and quality of life of low rectal cancer.
     J Surg Oncol. 2022;125:484-492.
     PubMed     Abstract available
     
     
     
101. HREBINKO KA, Reitz KM, Mohammed MK, Nassour I, et al
     Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.
     J Surg Oncol. 2022;125:475-483.
     PubMed     Abstract available
     
     
     
102. SHANNON AB, Straker RJ, Keele L, Kelz RR, et al
     The impact of hospital volume on racial disparities in resected rectal cancer.
     J Surg Oncol. 2022;125:465-474.
     PubMed     Abstract available
     
     
     
103. HE S, Liu Z, Li L, Zhang J, et al
     Improvement of low anterior resection syndrome beyond 2 years after total mesorectal excision.
     J Surg Oncol. 2022;125:448-456.
     PubMed     Abstract available
     
     
     
104. JAGANMURUGAN R, Kazi M, Sukumar V, Gori J, et al
     Bladder preserving robotic pelvic exenteration for locally advanced rectal cancer-technique and short-term outcomes.
     J Surg Oncol. 2022;125:493-497.
     PubMed     Abstract available
     
     
     
105. FERRAL H, Alonzo MJ, Datri J, Hogg ME, et al
     Endovascular management of portal vein obstruction in hepatobiliary cancer patients.
     J Surg Oncol. 2022;125:392-398.
     PubMed     Abstract available
     
     
     
106. NI K, Zhan Y, Liu Z, Zhao XZ, et al
     Mismatch repair system deficiency is associated with chemoradiotherapy resistance in locally advanced rectal adenocarcinoma patients.
     J Surg Oncol. 2022;125:692-702.
     PubMed     Abstract available
     
     
     
107. MANGIERI CW, Moaven O, Valenzuela CD, Erali RA, et al
     Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery.
     J Surg Oncol. 2022;125:703-711.
     PubMed     Abstract available
     
     
     
108. KOLBEINSSON HM, Hoppe A, Walker J, Chandana S, et al
     Recurrence and survival after curative-intent treatment for colorectal liver metastases: Implications for adjuvant liver-directed regional chemotherapy.
     J Surg Oncol. 2022;125:664-670.
     PubMed     Abstract available
     
     
     February 2022
109. SUN Y, Yu D, Zhong J, Lin Y, et al
     Para-aortic lymph node dissection in left-sided colorectal cancer: Risk factors, prognostic impact, and therapeutic value.
     J Surg Oncol. 2022 Feb 24. doi: 10.1002/jso.26829.
     PubMed     Abstract available
     
     
     
110. HUANG Z, Cai P, Zhao Y, Niu D, et al
     Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
     J Surg Oncol. 2022 Feb 17. doi: 10.1002/jso.26823.
     PubMed     Abstract available
     
     
     
111. CUIJPERS ACM, Bongers BC, Heldens AFJM, Bours MJL, et al
     Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
     J Surg Oncol. 2022 Feb 11. doi: 10.1002/jso.26817.
     PubMed     Abstract available
     
     
     
112. VALADAO M, Cesar D, Veo CAR, Araujo RO, et al
     Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer.
     J Surg Oncol. 2022;125:194-216.
     PubMed     Abstract available
     
     
     January 2022
113. ADACHI Y, Tokunaga R, Matsumoto K, Nakao Y, et al
     What are the factors predictive of postoperative complications in patients with colorectal cancer undergoing stenting as a bridge to surgery?
     J Surg Oncol. 2022 Jan 31. doi: 10.1002/jso.26803.
     PubMed     Abstract available
     
     
     
114. NARAYAN RR, Aveson VG, Chou JF, Walch HS, et al
     Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.
     J Surg Oncol. 2022 Jan 23. doi: 10.1002/jso.26797.
     PubMed     Abstract available
     
     
     
115. PARK LJ, Daza JF, Li V, Workneh A, et al
     Prognostic factors of overall survival in patients with recurrent disease following liver resection for colorectal cancer metastases: A multicenter external validation study.
     J Surg Oncol. 2022 Jan 20. doi: 10.1002/jso.26796.
     PubMed     Abstract available
     
     
     
116. FOSTER JM, Alexander HR, Zhang C
     Regional therapy trials in peritoneal metastases: The path to standardization-Colorectal cancer.
     J Surg Oncol. 2022;125:57-63.
     PubMed    
     
     
     
117. WHELAN S, Burneikis D, Kalady MF
     Rectal cancer: Maximizing local control and minimizing toxicity.
     J Surg Oncol. 2022;125:46-54.
     PubMed     Abstract available
     
     
     December 2021
118. CHODOFF A, Smith KC, Shukla A, Blackford AL, et al
     Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations.
     J Surg Oncol. 2021 Dec 11. doi: 10.1002/jso.26767.
     PubMed     Abstract available
     
     
     
119. SERRANO PE, Parpia S, Karanicolas P, Gallinger S, et al
     Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial.
     J Surg Oncol. 2021 Dec 8. doi: 10.1002/jso.26764.
     PubMed     Abstract available
     
     
     
120. KIM JC, Ha YJ, Park IJ, Kim CW, et al
     Tumor immune microenvironment of primary colorectal adenocarcinomas metastasizing to the liver or lungs.
     J Surg Oncol. 2021;124:1136-1145.
     PubMed     Abstract available
     
     
     
121. YANG W, Liu Q, Lin G, Zhang B, et al
     The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
     J Surg Oncol. 2021;124:1128-1135.
     PubMed     Abstract available
     
     
     
122. YOON DH, Ibrahim A, Tatishchev S, Duldulao MPN, et al
     Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
     J Surg Oncol. 2021;124:1091-1097.
     PubMed     Abstract available
     
     
     
123. WANG Y, Zhang Y, Lin H, Xu M, et al
     Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
     J Surg Oncol. 2021;124:1098-1105.
     PubMed     Abstract available
     
     
     
124. LI Z, Wang Y, Ying X, Zhang L, et al
     Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
     J Surg Oncol. 2021;124:1356-1364.
     PubMed     Abstract available
     
     
     
125. MENG W, Yang B, Huang B, Chen C, et al
     Impact of preoperative transcatheter rectal arterial chemoembolization with concurrent chemoradiotherapy on surgery and prognosis of patients with locally advanced rectal cancer.
     J Surg Oncol. 2021;124:1451-1458.
     PubMed     Abstract available
     
     
     
126. DAMASCENO AM, Kesley R, Paolino BS, Dos Santos do Amaral MR, et al
     Perioperative score for octogenarian patients eligible for rectal cancer surgery.
     J Surg Oncol. 2021;124:1409-1416.
     PubMed     Abstract available
     
     
     
127. KAZI M, Jain D, Padhy AS, Menon M, et al
     Optimal neoadjuvant strategy for signet ring cell carcinoma of the rectum-Is TNT the solution?
     J Surg Oncol. 2021;124:1417-1430.
     PubMed     Abstract available
     
     
     November 2021
128. BRAJCICH BC, Benson AB, Gantt G, Eng OS, et al
     Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
     J Surg Oncol. 2021 Nov 25. doi: 10.1002/jso.26758.
     PubMed     Abstract available
     
     
     
129. HU Q, Sun YS, Yang XY
     Comment on "Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure".
     J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26580.
     PubMed    
     
     
     October 2021
130. NUMATA M, Shiozawa M, Godai T, Kazama K, et al
     Prediction of lateral lymph node metastasis using OSNA method for mesorectal lymph nodes in low rectal cancer: A prospective study by the Kanagawa Yokohama Colorectal Cancer Study Group (KYCC1801).
     J Surg Oncol. 2021 Oct 27. doi: 10.1002/jso.26730.
     PubMed     Abstract available
     
     
     September 2021
131. REUDINK M, Molenaar CJL, Bonhof CS, Janssen L, et al
     Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
     J Surg Oncol. 2021 Sep 27. doi: 10.1002/jso.26685.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: